Preview Mode Links will not work in preview mode

Jun 26, 2024

Featuring perspectives from Ms Jamie Carroll, Ms Kelly EH Goodwin, Dr Erika Hamilton and Dr Hope S Rugo, including the following topics:

  • Introduction (0:00)
  • Overview of Antibody-Drug Conjugates (ADCs); HER2-Targeted ADCs for Breast Cancer — T-DM1, Trastuzumab Deruxtecan (7:22)
  • The Incidence and Management of...


Apr 4, 2024

Featuring perspectives from Dr Manish Patel, including the following topics:

  • Insights into a comprehensive clinical research practice (0:00)
  • Transformation of the conduct and design of clinical trials (3:41)
  • Disparities and conundrums in clinical trial recruitment (10:11)
  • Rationale of clinical trial dosing and...


Aug 30, 2023

Featuring perspectives from Dr Richard F Riedel, including the following topics:

  • Introduction: (0:00)
  • Case: A woman in her late 20s with multiregimen-recurrent metastatic alveolar soft part sarcoma after treatment with multiple VEGF tyrosine kinase inhibitors and a single-agent PD-1 inhibitor receives...


Jun 16, 2023

Featuring perspectives from Dr Brian Van Tine, including the following topics:

  • Introduction (0:00)
  • Case: A man in his mid 30s with metastatic recurrence of alveolar soft part sarcoma of the shoulder who received ipilimumab/nivolumab; imaging scan suspect for pseudoprogression — Nam Q Bui, MD (11:20)
  • Case: A woman in...


Mar 16, 2022

Featuring perspectives from Drs Roy Herbst, Sara Tolaney and Jeffrey Weber, including the following topics:

  • Introduction (0:00)
  • Snapshot of Key Trials/Interdisciplinary Impact (12:58)
  • Estimates of Benefit with Adjuvant Treatment (27:35)
  • Risks of Adjuvant Therapies (36:56)
  • Adjuvant Therapy Decision-Making (43:39)
  • Future...